Epigenetic silencing and pharmacological inhibition of <i>EIF5A2</i> foster venetoclax sensitivity in acute myeloid leukaemia
We show how the loss of activity of the translation initiation factor EIF5A2-either through gene hypermethylation or pharmacologic inhibition of its highly specific hypusine post-translational modification-induces venetoclax sensitivity in acute myeloid leukaemia (AML) cells.
Authors
- Manel Esteller
- Laia Sancho‐Vila
- Eva Crespo‐García
- Aleix Noguera‐Castells
- Laura Martinez‐Verbo
- Carlos Quero‐Dotor
Institutions
- Universitat de Vic - Universitat Central de Catalunya (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Josep Carreras Leukaemia Research Institute (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Universitat de Barcelona (ES)
- Epigenomics (Germany) (DE)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1111/bjh.70339
- Primary Topic
- Polyamine Metabolism and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00